Literature DB >> 169287

Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.

K Megyesi, C R Kahn, J Roth, P Gorden.   

Abstract

The insulin-like peptide NSILA-s (non-suppressible insulin-like activity soluble in acid ethanol) was measured in plasma using gel filtration in acid and a new radioreceptor assay. Total plasma NSILA-s levels, which are elevated in some patients with extrapancreatic tumors and hypoglycemia, were also found to be elevated in pregnancy. Patients with hypopituitarism had subnormal concentrations of total plasma NSILA-s which rose promptly and reached a peak 1 h after intravenous hGH. In contrast ot this acute stimulus, chronic elevation of hGH resulted in an elevated level of NSILA-s in only 1 of 10 acromegalics. In normal subjects, oral glucose loading resulted in a rise in NSILA-s (mean peak equals 151% of basal) while insulin induced hypoglycemia produced a small and variable fall. Among the other conditions studied, anorexia nervosa was associated with low levels of NSILA-s. Using gel filtration we found that at physiologic pH about 93% of endogenous NSILA-s is reversibly bound to larger molecules. We show that in normal adults the insulin-like bioactivity in plasma due to free NSILA-s in the basal state is equal to that exerted by insulin itself, and that the free NSILA-s in the circulation of patients with extra-pancreatic tumors approximates the elevated level of insulin in patients with insulin-secreting pancreatic tumors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169287     DOI: 10.1210/jcem-41-3-475

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.

Authors:  C R Kahn; K Megyesi; J Roth
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

2.  The excretion of insulin in urine.

Authors:  R M El-Allawy; O Sonne; J Gliemann; H Orskov; K Johansen
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

3.  Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.

Authors:  J Zapf; E Schoenle; G Jagars; I Sand; J Grunwald; E R Froesch
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

4.  NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.

Authors:  C Meuli; J Zapf; E R Froesch
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

5.  Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.

Authors:  E T Shapiro; G I Bell; K S Polonsky; A H Rubenstein; M C Kew; H S Tager
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

6.  Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Authors:  W H Daughaday; M Kapadia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Peripheral tissue metabolism in cancer-bearing man.

Authors:  M E Burt; T T Aoki; C M Gorschboth; M F Brennan
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

Review 8.  Paraneoplastic syndromes.

Authors:  D C Stolinsky
Journal:  West J Med       Date:  1980-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.